This is a modal window.
Can you describe a case where Shockwave significantly altered the course of the procedure?
Intravascular Lithotripsy (IVL) offers significant benefits as an additional calcium modification tool in your armamentarium, allowing you to:
MINIMIZE TRAUMA - Minimize trauma to soft tissue...
Intravascular Lithotripsy (IVL) offers significant benefits as an additional calcium modification tool in your armamentarium, allowing you to:
MINIMIZE TRAUMA - Minimize trauma to soft tissue by safely selecting and fracturing intimal and medial calcium
OPTIMIZE OUTCOMES - Optimize stent delivery, expansion and apposition while reducing complications and cost escalation
SIMPLIFY PROCEDURES - Simple and intuitive system that makes complex calcified coronary procedures more predictable
Find out more about Shockwave Lithotripsy: www.rutherfordmedicine.com/shockwavemedical
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its...
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its unique MOA.
Prior to use, please reference the instructions for use and important safety information: https://shockwavemedical.com/important-safety-information-universal/
Discover more at ShockwaveIVL.com
Speakers
Peter O'Kane
Speaker
Dr Peter O’Kane graduated from Charing Cross & Westminster Medical School in 1995 with First... Dr Peter O’Kane graduated from Charing Cross & Westminster Medical School in 1995 with First Class Honours Bachelor of Science BSc degree in Physiology, Medical Degree and numerous prizes including the Llewelyn Prize for the second-best distinction in medical finals. After attaining membership of the Royal College of Physicians he was subsequently awarded a Doctorate of Medicine by the University of London for a thesis on the role of nitric oxide in coronary heart disease. Dr O’Kane was appointed as Consultant Interventional Cardiologist at the Royal Bournemouth Hospital in July 2007. He has performed over 7000 PCI procedures as a Consultant. He routinely treats extensively calcified lesions, bifurcations including left main stem disease & chronic total occlusions. He is committed to teaching & education with local fellowship training program through to national & international proctorship of techniques & multiple adjunctive devices. He has trained Consultant colleagues from the UK, Europe, Asia & USA through local workshops and courses. He is regularly invited as faculty to National & International meetings as a presenter & live case operator. He has published over 70 manuscripts and authored 10 book chapters. He is a local principal Investigator for over 30 National & International multi-centre clinical trials & is dedicated to patient recruitment with over 900 patients recruited to trials he has managed. He has led numerous quality improvement programs, is PCI Lead, Cardiology Governance and Mortality Lead & has achieved National Bronze Clinical Excellence Award level 9. He was a nationally elected member to British Cardiovascular Intervention Society (BCIS) Council (2020-2023) and from March 2023 is a member of BCIS Research Working Group.
